Reaction
Skin Sensitisation reporting signals
As of the last recalculation, Skin Sensitisation appears in 1,023 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is METHIMAZOLE (PRR 23.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methimazole | 9 | 23.5 | 23.5 |
| Octreotide Acetate | 33 | 22.6 | 22.6 |
| Omalizumab | 52 | 13.0 | 13.0 |
| Sunitinib Malate | 24 | 12.7 | 12.7 |
| Epoprostenol | 8 | 12.5 | 12.5 |
| Nilotinib | 15 | 10.5 | 10.5 |
| Imatinib Mesylate | 13 | 9.6 | 9.6 |
| Brimonidine Tartrate | 8 | 9.2 | 9.2 |
| Minoxidil Foam 5% (Womens) | 9 | 5.6 | 5.6 |
| Minoxidil | 10 | 4.6 | 4.6 |
| Tirzepatide | 31 | 4.0 | 4.0 |
| Adapalene | 4 | 0.4 | 0.4 |